Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fatigue × Sunitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 100 Kidney Neoplasms 34 Neoplasms 29 Neoplasm Metastasis 27 Breast Neoplasms 27 Gastrointestinal Stromal Tumors 22 Carcinoma, Non-Small-Cell Lung 20 Prostatic Neoplasms 12 Urinary Bladder Neoplasms 11 Glioblastoma 11 Colorectal Neoplasms 11 Pancreatic Neoplasms 9 Lung Neoplasms 9 Brain Neoplasms 9 Melanoma 8 Carcinoma 8 Stomach Neoplasms 7 Sarcoma 7 Neuroendocrine Tumors 7 Carcinoma, Hepatocellular 7 Thyroid Neoplasms 6 Small Cell Lung Carcinoma 6 Ovarian Neoplasms 6 Adenoma, Islet Cell 6 Uveal Melanoma 5 Solid Tumors 5 Multiple Myeloma 5 Liver Neoplasms 5 Leukemia, Myeloid, Acute 5 Esophageal Neoplasms 5

Interventions

Exercise 26 Therapeutics 19 Modafinil 16 Yoga 15 Methylphenidate 14 Surveys and Questionnaires 9 Acupuncture Therapy 9 Psychiatric Rehabilitation 8 Educational Status 8 Cognitive Behavioral Therapy 8 Walking 7 Control Groups 7 Ultraviolet Therapy 6 Exercise Therapy 6 Early Intervention, Educational 6 Acceptance and Commitment Therapy 6 Therapeutic Touch 5 Physical Therapy Modalities 5 Counseling 5 Palliative Care 4 Methods 4 Epoetin Alfa 4 Dexamethasone 4 Behavior Therapy 4 Touch 3 Sugars 3 Standard of Care 3 Sodium Chloride 3 Saline Solution 3 Resistance Training 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02446795 2017-01-18

QUASAR

Consorzio Oncotech

Phase 1/2 Unknown

Carcinoma, Renal Cell, Fatigue, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡